ISMRC 2023 Final Programme

20 Poster Sessions – Tuesday, 2 May 2023 PS-01 04:15 – 06:15 p.m. Liquid biopsy-based Detection of primary Cancer and MRD – Part I Room: Conference 3C – ePoster station 1 Chair: Claus Lindbjerg Andersen, Denmark PS-01-001 Investigating Homologous Recombinati- on Deficiency in mCRPC through ctDNA Georgios Vlachos, Austria PS-01-002 Identification of Therapeutically Rele- vant Mutations in Circulating Tumor DNA at Baseline to Assist in Treatment Decision Making Paul van der Leest, The Netherlands PS-01-003 Epigenetic Biomarker Identification in Prostate Cancer using Liquid Biopsy Approaches Rakesh Trivedi, USA PS-01-005 Detection of minimal residual disease in acute myeloid leukemia using micro- fluidics Alexandra Teixeira, Portugal PS-01-006 Optimization of the characterization of plasma cell-free DNA integrity using a droplet-based digital PCR multiplex assay: towards the development of cir- culating tumor DNA multiplex assay Valerie Taly, France PS-01-007 ddPCR, qPCR, and NGS performance to detect KRAS and EGFR mutations in plasma cell-free DNA of stage IIIB/ IV lung adenocarcinoma patients, and comparison with the tissue molecular profile Ernst Jan Speel, The Netherlands PS-01-008 Cross-Platform Biomarker Program for Establishment and Validation of Liquid Biopsy for Clinical Decision Making in resectable Gastrointestinal Stromal Tu- mour (GIST) Helen Sievert, Germany PS-01-009 Identifying the Levers of Cost-Effective- ness of Next-Generation-Sequencing- Based Liquid Biopsy for Colorectal Cancer in France, Spain, and Germany Wendelin Schramm, Germany PS-01-010 Quantitative detection of cell free HPV DNA in plasma samples using Nanopore Sequencing Oliver Schauer, Germany General note: In the below listed poster sessions we have only disclosed the pre- senting authors. The full details including co-authors can be found in the abstracts on the website. The poster terminals are located in the rooms Conference 3C and 3D on the third floor.